unknown
Stage
1
Investors
About
Clerio Vision develops non-invasive vision-correction technologies for the eye, including a tissue-sparing corneal refractive approach that modifies corneal refractive index for the intraocular lens market, a premium contact lens for older adults, and a non-cutting corneal refractive surgery alternative to LASIK.
Explore Clerio Vision's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.